This site is intended for Healthcare Professionals only.

Novavax files for authorisation of Covid-19 shot among adolescents in Britain

Date:

Share post:

Novavax Inc said on Wednesday (May 4) it had filed an application with The Medicines and Healthcare products Regulatory Agency for the authorisation of its Covid-19 vaccine among adolescents aged 12 and older.

The medicines regulator had in February cleared the two-dose vaccine, Nuvaxovid, for use in adults amid a spike in cases fuelled by the Omicron variant of the coronavirus.

Novavax’s submission includes data from a late-stage trial in the United States, where the vaccine showed 80 per cent efficacy among adolescents when Delta was the dominant variant in the country.

The drugmaker in late January filed for emergency use authorisation of its Covid-19 shot for adults in the United States.

The U.S. Food and Drug Administration plans to hold several meetings of its outside panel of experts in June to discuss authorisation requests submitted by multiple Covid-19 vaccine manufacturers including Novavax.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

How Bioprocess Containers Improve Vaccine Transportation

Have you ever wanted to know how vaccines are sent out from a lab to your doctor’s office...

Celebrating the Festival of Lights: Diwali messages from pharmacy leaders

As the country celebrates Diwali, symbolising the victory of good over evil and of light over darkness, Pharmacy...

Autumn Budget 2024: Pharmacies ‘deeply worried’ about National Insurance rise

No mention of action to halt pharmacy closure in the Autumn Budget upsets community pharmacies The new Labour...

Autumn Budget 2024: What it has for retail businesses?

The new Labour government’s first Budget reduces business rates and allocates £1.9 billion to support small businesses and...